Takeda Pharmaceutical Company Limited (TAK) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 2:35 PM EDT
Company Participants
Andrew Plump – President of Research & Development and Representative Director
Rhonda Pacheco – President of U.S. Business Unit & U.S. Country Head
Conference Call Participants
Shinichiro Muraoka – Morgan Stanley, Research Division
Presentation
Shinichiro Muraoka
Morgan Stanley, Research Division
Okay. Let’s get started the session with Takeda Pharmaceutical. Before starting this session, for important disclosures, please see our www.morganstanley.com/researchdisclosures website. If you have further questions, please reach out to our Morgan Stanley representatives. So yes, let me start the session with Takeda. The speakers are Andy Plump, Head of R&D; and Rhonda Pacheco from U.S. business Unit Head. Thank you, Andy and Rhonda, thank you for joining us today.
Andrew Plump
President of Research & Development and Representative Director
Yes. Thank you.
Rhonda Pacheco
President of U.S. Business Unit & U.S. Country Head
Great to be here.
Question-and-Answer Session
Shinichiro Muraoka
Morgan Stanley, Research Division
Yes. Thank you. Thank you. So before starting our session, I’d like to say great gratitude to Andy. according to a couple of days ago, the press release, you are retiring from the current role. You have contributed more than 15 years at Takeda. And now you have built up huge pipeline franchise. Thank you for your great achievement in the last more than 10 years. And I’m a bit sorry for that.
Andrew Plump
President of Research & Development and Representative Director
Thank you very much, Muraoka-san. We’ve had a long time together. In all the quarterly earnings reports that we’ve been in together, you’ve asked me a lot of really hard questions. It’s not the reason I’m retiring, but it’s an upside. Not have to take your hard questions. but thank you. It’s been a privilege to serve in this role for the
